Literature DB >> 11230747

Immunolocalization of a novel cholesteryl ester hydrolase in the endoplasmic reticulum of murine and human hepatocytes.

O Fresnedo1, M L De Heredia, M J Martínez, S Cristóbal, M T Rejas, J M Cuezva, B Ochoa.   

Abstract

We have recently purified a cholesteryl ester hydrolase (CEH) from rat liver microsomes. Antibodies raised against the purified protein specifically reacted with a 106-kd protein and neutralized 90% of the CEH activity of rat liver microsomes (J Lipid Res 1999;40:715-725). In this work we have used the anti-CEH antibody to study both the subcellular distribution of the protein in hepatocytes as well as its tissue-specific expression in rat. Western blotting of subcellular fractions obtained from isolated rat hepatocytes revealed that the immunoreactive 106-kd CEH was exclusively localized in microsomes. The antibody also recognized a 106-kd protein in microsomes from mouse and human liver but not from rat nonparenchymal liver cells. Confocal microscopy of HepG2 cells revealed that CEH immunoreactive material colocalized with calnexin, a marker of the endoplasmic reticulum. Furthermore, high-resolution immunoelectron microscopy of rat liver thin sections exclusively localized the CEH immunoreactivity to the endoplasmic reticulum of the hepatocyte. No CEH immunoreactivity was observed in microsomes derived from adrenal glands, ovaries, testis, pancreas, intestine, white adipose tissue, mammary gland, lung, spleen, brain, aorta, and macrophages. We report a CEH localized to the endoplasmic reticulum, erCEH, in the mammalian hepatocyte. The subcellular localization and tissue-restricted pattern of expression of erCEH suggests that it might have unique functions in liver cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230747     DOI: 10.1053/jhep.2001.22763

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Kathryn E Marqueen; Rachel Osborne; Genta Kakiyama; William Korzun; Siddhartha S Ghosh; Shobha Ghosh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-06       Impact factor: 8.311

2.  Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.

Authors:  Mariana Liza; Yolanda Chico; Olatz Fresnedo; Begoña Ochoa
Journal:  Lipids       Date:  2003-01       Impact factor: 1.880

3.  Association of SND1 protein to low density lipid droplets in liver steatosis.

Authors:  I Garcia-Arcos; Y Rueda; P González-Kother; L Palacios; B Ochoa; O Fresnedo
Journal:  J Physiol Biochem       Date:  2010-04-23       Impact factor: 4.158

4.  Tudor-SN Regulates Milk Synthesis and Proliferation of Bovine Mammary Epithelial Cells.

Authors:  Jinxia Ao; Chengjie Wei; Yu Si; Chaochao Luo; Wei Lv; Ye Lin; Yingjun Cui; Xuejun Gao
Journal:  Int J Mol Sci       Date:  2015-12-16       Impact factor: 5.923

5.  SREBP-2-driven transcriptional activation of human SND1 oncogene.

Authors:  Sandra Armengol; Enara Arretxe; Leire Enzunza; Irati Llorente; Unai Mendibil; Hiart Navarro-Imaz; Begoña Ochoa; Yolanda Chico; María José Martínez
Journal:  Oncotarget       Date:  2017-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.